Paul Herzich's most recent trade in Solid Biosciences Inc was a trade of 7,187 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 7,187 | 21,076 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 7,187 | 21,563 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 2,688 | 18,388 (0%) | 0% | 4.0 | 10,644 | Common Stock |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 98,700 | 98,700 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 7,239 | 14,959 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Herzich Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 7,239 | 14,478 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Herzich Paul | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 2,777 | 12,182 (0%) | 0% | 5.6 | 15,551 | Common Stock |
Solid Biosciences Inc | Herzich Paul | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 57,500 | 57,500 | - | - | Employee Stock Option (Right to Buy) | |
Solid Biosciences Inc | Herzich Paul | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 28,750 | 28,750 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Herzich Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 7,238 | 21,717 | - | - | Restricted Stock Units | |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 7,238 | 7,238 (0%) | 0% | - | Common Stock | |
Solid Biosciences Inc | Herzich Paul | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 02 Dec 2023 | 2,968 | 4,270 (0%) | 0% | 2.8 | 8,232 | Common Stock |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 57,900 | 57,900 | - | - | Stock Option (Right to Buy) | |
Solid Biosciences Inc | Paul Herzich | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 28,955 | 28,955 | - | - | Restricted Stock Units |